Erlotinib Induces Synthetic Lethality With the Poly(ADP-Ribose) Polymerase (PARP) Inhibitor ABT-888 in Esophageal Cancer

被引：1
|
作者：
Whitley, A. C. [1 ]
Jackson, J. [1 ]
Trummell, H. [1 ]
Bonner, J. [1 ]
Yang, E. S. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S165 / S166
页数：2
相关论文
共 50 条
  • [41] Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase
    Parise, Robert A.
    Shawaqfeh, Mohammad
    Egorin, Merrill J.
    Beumer, Jan H.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 872 (1-2): : 141 - 147
  • [42] Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias
    Karp, Judith E.
    Pratz, Keith W.
    Litzow, Mark R.
    Ji, Juping
    Chen, Alice
    Rudek, Michelle
    Kaufmann, Scott H.
    BLOOD, 2010, 116 (21) : 1342 - 1343
  • [43] Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells
    Ji, Jiuping
    Kinders, Robert J.
    Zhang, Yiping
    Rubinstein, Larry
    Kummar, Shivaani
    Parchment, Ralph E.
    Tomaszewski, Joseph E.
    Doroshow, James H.
    PLOS ONE, 2011, 6 (10):
  • [44] Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines
    Gangopadhyay, Nupur N.
    Luketich, James D.
    Opest, Amy
    Visus, Carmen
    Meyer, Ernest M.
    Landreneau, Rodney
    Schuchert, Matthew J.
    CANCER INVESTIGATION, 2011, 29 (09) : 608 - 616
  • [45] Poly (ADP Ribose) Polymerase Inhibition-with ABT-888 Alone and in Combination with Gemcitabine Enhances Radiosensitization of Pancreatic Cancer Cells
    Tuli, R.
    Surmak, A. J.
    Blackford, A.
    Reyes, J.
    Leubner, A.
    Zhang, Y.
    Zhou, H.
    Jaffee, E. M.
    DeWeese, T. L.
    Herman, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S653 - S654
  • [46] Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias
    Pratz, Keith W.
    Kaufmann, Scott H.
    Litzow, Mark R.
    Ji, Jiuping
    Chen, Alice
    Rudek, Michelle A.
    Karp, Judith E.
    BLOOD, 2011, 118 (21) : 1552 - 1552
  • [47] New inhibitors of poly(ADP-ribose) polymerase (PARP)
    Peukert, S
    Schwahn, U
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551
  • [48] Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
    Wiggans, Alison J.
    Cass, Gemma K. S.
    Bryant, Andrew
    Lawrie, Theresa A.
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [49] Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer
    Tanaka, Mamoru
    Sasaki, Makiko
    Suzuki, Taketo
    Nishie, Hirotada
    Kataoka, Hiromi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 539 : 1 - 7
  • [50] Beneficial effect of poly(ADP-ribose) polymerase (PARP) inhibitor in acute photodamage
    Farkas, B
    Csete, B
    Magyarlaki, M
    Németh, J
    Tubak, V
    Nagy, PL
    Sümegi, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (03) : 740 - 740
12345